SCHEMBL26847293

SCHEMBL26847293

Cc1c(F)cc(CSc2[nH]c(=O)cc(Cc3cccs3)c2C#N)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ GFER P55789 1/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ HTT P42858 2/20 0.36
▸ CXCR2 P25025 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ ACMSD Q8TDX5 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ PKM P14618 2/20 0.33
▸ USP2 O75604 1/20 0.33
▸ PRNP P04156 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24087879 0.90 ALDH1A1 (0.35) KDM4ETSHRGFERALDH1A1KMT2A
SCHEMBL26847291 0.85 ALDH1A1 (0.44) KDM4ETSHRGFERALDH1A1KMT2A
SCHEMBL26847345 0.83 KDM4E (0.46) KDM4ETSHRGFERALDH1A1KMT2A
SCHEMBL26847375 0.77 KDM4E (0.44) KDM4ETSHRGFERALDH1A1KMT2A
SCHEMBL24088104 0.76 ACMSD (0.59) KDM4ETSHRGFERKMT2AACMSD
SCHEMBL24087880 0.75 ALDH1A1 (0.42) KDM4ETSHRGFERALDH1A1KMT2A
SCHEMBL24088142 0.75 ACMSD (0.48) KMT2AACMSDMEN1PKMUSP2
SCHEMBL26847326 0.74 KDM4E (0.59) KDM4ETSHRGFERALDH1A1KMT2A
SCHEMBL26847309 0.74 ACMSD (0.39) KDM4ETSHRGFERKMT2AACMSD
SCHEMBL24087956 0.73 KDM4E (0.46) KDM4ETSHRALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885TSHR 4829/4885GFER 596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback